Related Experiment Video
Updated: Sep 23, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Treatment of the patient with primary familial heterozygous hypercholesterolemia
1Lipid Institute, Sequoia Hospital, Redwood City, California, USA.
Insights
Familial heterozygous hypercholesterolemia (FH) is a genetic lipid disorder causing high cholesterol. This case study highlights how nursing care improved patient adherence to a 4-year treatment plan for FH and coronary heart disease.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Metabolic Disorders
Background:
- Familial heterozygous hypercholesterolemia (FH) is an inherited condition characterized by elevated total cholesterol and LDL cholesterol.
- Approximately 5% of individuals with coronary heart disease (CHD) have FH, indicating a significant overlap between these conditions.
- Standard treatment for FH includes lifestyle modifications (diet, weight management, exercise) and pharmacotherapy.
Observation:
- A case study details a patient's 4-year treatment journey following a CHD diagnosis, complicated by FH.
- The patient's adherence to the prescribed treatment regimen was a critical factor in managing their condition.
- Nursing interventions played a pivotal role in supporting the patient's compliance throughout the treatment period.
Findings:
- Effective management of FH in patients with CHD requires a comprehensive approach.
- Sustained patient adherence to treatment is crucial for mitigating cardiovascular risk.
- Nursing care is instrumental in facilitating patient adherence and improving outcomes in complex lipid disorders.
Implications:
- This case underscores the importance of integrating genetic lipid disorder management into cardiovascular care pathways.
- Enhanced patient education and support, particularly from nursing staff, can significantly improve treatment adherence in FH.
- Further research into the long-term impact of nursing interventions on FH management and cardiovascular outcomes is warranted.
Abstract:
Familial heterozygous hypercholesterolemia (FH) is a genetically linked lipid disorder that involves elevations in total cholesterol and LDL cholesterol. About 5% of patients with coronary heart disease have FH. Treatment options include dietary therapy, weight optimization, exercise, and drug treatment. A case study of a patient who has undergone 4 years of treatment for FH after a diagnosis of coronary heart disease is presented. Nursing care was instrumental in the patient's compliance with and adherence to the treatment plan.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacogenomics: Identification of New Drug Targets
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Atherosclerosis IV: Nursing Management

